Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cognition Therapeutics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cognition Therapeutics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| BIOS Memory SPV I, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| BIOS Fund I, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| BIOS Fund I QP, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| BIOS Fund II, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| BIOS Fund II QP, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| Fletcher Aaron G.L. | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| Bios Equity Partners II, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| Bios Equity Partners, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| BIOS Advisors GP, LLC | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| BIOS Capital Management, LP | Director, 10% Owner | 81,229 | Jun 22, 2026 | 1 |
| Richstone Ellen B | Director | 83,500 | Jun 22, 2026 | 1 |
| Monia Brett P | Director | 73,500 | Jun 22, 2026 | 1 |
| Khattar Jack A. | Director | 73,500 | Jun 22, 2026 | 1 |
| Wallace Peggy | Director | 111,461 | Jun 22, 2026 | 1 |
| Doyle John Brendan | Chief Financial Officer | 618,942 | May 4, 2026 | 5 |
| Ricciardi Lisa | CEO & President | 1,715,851 | Apr 20, 2026 | 4 |
| Caggiano Anthony | Chief Medical Officer | 874,906 | Apr 20, 2026 | 4 |
| BIOS Memory SPV II, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| BIOS Fund II NT, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| BIOS Fund III NT, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| BIOS Fund III QP, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| BIOS Fund III, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| Cavu Management, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| Cavu Advisors, LLC | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| BP Directors, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| Kreis Leslie W. | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| BIOS Equity Partners III, LP | Director, 10% Owner | 48,500Indirect | Jun 20, 2025 | 0 |
| Golden Seeds Cognition Therapeutics LLC | 10% Owner | 0 | Sep 29, 2022 | 0 |
| O'Brien James Michael | Chief Financial Officer | 5,000 | Mar 25, 2022 | 0 |
| Ogden CAP Associates, LLC | 10% Owner | 2,210,377 | Oct 15, 2021 | 0 |
| Breedlove Mark H. | Director | 404,439Indirect | Oct 15, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Doyle John BrendanChief Financial Officer | PPurchase | +10.0K | $1.13 | +$11.3K | +1.6%627.5K after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Ricciardi LisaCEO & President | PPurchase | +9.18K | $1.10 | +$10.1K | +0.5%1.72M after | |
| Apr 20, 2026 (view filing) | Apr 16 | 4 days | Caggiano AnthonyChief Medical Officer | PPurchase | +10.0K | $1.11 | +$11.1K | +1.2%874.9K after | |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Ricciardi LisaCEO & President | PPurchase | +38.9K | $0.77 | +$29.9K | New position38.9K after | |
| Mar 14, 2024 (view filing) | Mar 14 | Same day | Ricciardi LisaCEO & President | PPurchase | +5.70K | $1.75 | +$9.97K | +2.0%291.3K after | |
| Nov 29, 2022 (view filing)7:02 AM ET | Nov 28 | 1 day | BIOS Memory SPV I, LP and 9 othersDirector, 10% Owner | PPurchase | +16.1K | $2.65 | +$42.6K | +5.5%309.7K after | 3 lotsDuplicate filing |
| Nov 29, 2022 (view filing)7:00 AM ET | Nov 28 | 1 day | BIOS Memory SPV II, LP and 8 othersDirector, 10% Owner | PPurchase | +16.1K | $2.65 | +$42.6K | +5.5%309.7K after | 3 lots |
| Nov 29, 2022 (view filing) | Nov 29 | Same day | Richstone Ellen BDirector | PPurchase | +10.0K | $2.66 | +$26.6K | New position10.0K after | |
| Nov 17, 2022 (view filing)7:00 AM ET | Nov 16 | 1 day | Fletcher Aaron G.L. and 9 othersDirector | PPurchase | +71.0K | $1.40 | +$99.4K | +30.0%307.9K after | 3 lotsDuplicate filing |
| Nov 17, 2022 (view filing)7:00 AM ET | Nov 16 | 1 day | Kreis Leslie W. and 8 othersDirector | PPurchase | +71.0K | $1.40 | +$99.4K | +30.0%307.9K after | 3 lots |
| Nov 16, 2022 (view filing)7:00 AM ET | Nov 15 | 1 day | Fletcher Aaron G.L. and 9 othersDirector | PPurchase | +1.50M | $1.20 | +$1.80M | New position299.6K after | 3 lotsDuplicate filing |
| Nov 16, 2022 (view filing)6:59 AM ET | Nov 15 | 1 day | Kreis Leslie W. and 8 othersDirector | PPurchase | +1.50M | $1.20 | +$1.80M | New position299.6K after | 3 lots |
| Nov 16, 2022 (view filing) | Nov 15 | 1 day | Ricciardi LisaCEO & President | PPurchase | +12.0K | $1.30 | +$15.6K | +96.0%24.5K after | |
| Nov 16, 2022 (view filing) | Nov 15 | 1 day | Wallace PeggyDirector | PPurchase | +12.5K | $1.20 | +$15.0K | +49.1%38.0K after | |
| Oct 25, 2021 (view filing) | Oct 13 | 12 daysLate | Wallace PeggyDirector | PPurchase | +3.00K | $12.00 | +$36.0K | New position3.00K after | |
| Oct 15, 2021 (view filing)9:54 PM ET | Oct 13 | 2 days | BIOS Memory SPV I, LP10% Owner | PPurchase | +190.0K | $12.00 | +$2.28M | +26.8%899.9K after | 3 lotsDuplicate filing |
| Oct 15, 2021 (view filing)9:54 PM ET | Oct 13 | 2 days | BIOS Memory SPV I, LP10% Owner | SSale | −90.28 | $12.00 | −$1.08K | 0.0%385.2K after | Duplicate filing |
| Oct 15, 2021 (view filing)9:51 PM ET | Oct 13 | 2 days | Fletcher Aaron G.L.Director | PPurchase | +190.0K | $12.00 | +$2.28M | +26.8%899.9K after | 3 lots |
| Oct 15, 2021 (view filing)9:51 PM ET | Oct 13 | 2 days | Fletcher Aaron G.L.Director | SSale | −90.28 | $12.00 | −$1.08K | 0.0%385.2K after | |
| Oct 15, 2021 (view filing)9:51 PM ET | Oct 13 | 2 days | Golden Seeds Cognition Therapeutics LLC10% Owner | SSale | −33.09 | $12.00 | −$397.08 | 0.0%2.18M after | |
| Oct 15, 2021 (view filing)9:51 PM ET | Oct 13 | 2 days | Ogden CAP Associates, LLC10% Owner | SSale | −74.05 | $12.00 | −$888.6 | 0.0%2.21M after | |
| Oct 15, 2021 (view filing)9:02 PM ET | Oct 13 | 2 days | Breedlove Mark H.Director | SSale | −11.74 | $12.00 | −$140.88 | 0.0%404.4K after | |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | Ricciardi LisaCEO & President | PPurchase | +12.5K | $12.00 | +$150.0K | New position12.5K after | |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | O'Brien James MichaelChief Financial Officer | PPurchase | +5.00K | $12.00 | +$60.0K | New position5.00K after |